USPTO serial 98229561
MIRACULIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 25, 2025
- Examiner
- HURTADO,DIANA V
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MIRACULIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Susan Spiering
M. Susan Spiering Ochoa & Associates, P.C.4921 Williams DriveCorpus Christi, TX 78411United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Laboratory reagents for scientific use; Tagged antibodies; Media for use in chromatography; Chemical reagent mixtures in kit form; Chemical reagent mixtures; Monoclonal antibodies; Monoclonal antibodies for diagnostic use; Monoclonal antibodies for industrial use; Monoclonal antibody reagents; Testing reagents for industrial use, namely, for qualitative and quantitative analysis of compounds; Reagents for use in analytical tests; Reagents for use in analysis; Reagents for use in biological processing; Reagents for scientific purposes; Reagents for use in diagnostic tests; Reagents for analytical purposes; Reagents for use in the development of monoclonal antibodies; Reagents for medical research; Reagents for industrial purposes; Reagents for laboratory purposes; Reagents for microbiological analysis; Reagents for use in environmental analysis; Reagents for testing water; Reagents for scientific or medical research use; Reagents for in-vitro laboratory use; Reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA); Reagents for research purposes; Reagents for use with analyzers; Reagents for use in scientific apparatus for chemical or biological analysis; Reagent paper; Reagent test strips other than for medical or veterinary use; Testing reagents other than for medical or veterinary use; Test paper, chemical; Inorganic chemicals for use in industry; Inorganic chemical for use in science; Antibody reagents for scientific purposes; Antibodies for scientific purposes; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemical preparations for scientific purposes; Biochemical reagents used for non-medical purposes; Chemicals for use in immuno-assay testing, namely, in the testing of drug substances; Chemicals for use in analysis, namely, in the testing of drug substances; Chemically treated non-medical test strips; Chemical reagents for use in diagnosis; Chemical diagnostic reagents for industrial use; Chemicals for use in chromatography; Chemical substances for analyses in laboratories; Chemical products for diagnostic use; Chemicals for the control of environmental pollution; Chromatography chemicals; Chemicals for use in industry and science; Chemicals for use in scientific analysis; Chemicals for use in agriculture, except fungicides, herbicides, insecticides, and parasiticides; Chemical preparations for use in the food industry; Chemicals for use in the pharmaceutical industry; Chemicals for use in biotechnological product development; Chemicals for use in biotechnological manufacturing processes; Chemical reagents; Chemical reagents for use in biotechnology; Chemical reagents for use in diagnostic tests; Chemical reagents for use in science; Chemical reagents for use in analytical tests; Chemical reagents for use in industry; Chemical reagents for molecular biology; Chemical reagents for identification of microorganisms; Chemical reagents for use with immunoassay analyzers; Chemical substances for use in the biotechnological industry; Chemical substances for use in manufacture; Chemical substances for analysis in laboratories; Chemical testing kits for determining water properties; Chemical test paper for use with assays; Diagnostic preparations for scientific or research use; Insemination result control diagnosis reagents; Diagnostic preparations for scientific purposes; Diagnostic reagents for in-vitro use; Diagnostic substances for scientific or research use; Diagnostic chemicals for scientific use; In-vivo diagnostic reagents; Diagnostic reagents, except for medical or veterinary use; Diagnostic reagents; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents and preparations, except for medical or veterinary use; Extraction chemicals; Chemically sensitized photographic color paper; Dyes, namely, dyes used in the qualitative and quantitative testing of drug samples for scientific or research use; Fine chemicals, namely, fine chemicals used in qualitative and quantitative testing of drug samples; Fluorescent chemicals for use as a fluorescent label; Fluorescent substances, namely, fluorescent dye; Immunoassay reagents; Immunological antibodies; Indicators, namely, indicators used to detect the presence of drugs or contaminants in a sample other than for medical or veterinary purposes; Calibration fluids, namely, for use in qualitative or quantitative drug testing kits for scientific or research use; Calibration fluids for medical apparatus for scientific or research use; Biomolecule labeling kits comprising reagents for use in scientific research; Chemical test reagents; all of the foregoing for scientific, laboratory, or research use or purposes, and not for medical or veterinary use or purposes | ACTIVE | — |
| 005 | Antibodies; Biological reagents; Chemical reagents; Diagnostic chemical reagents; Diagnostic preparations; Diagnostic agents for pharmaceutical use; Diagnostic biomarker reagents; Diagnostic reagents; Diagnostic substances; Immunoassay reagents; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in analysis of chemical compounds and drug substances; Reagents for use in diagnostic tests; Clinical diagnostic reagents; Diagnostic reagents for in-vitro laboratory testing; Reagents; Reagents for microbiological analysis; Reagents and media; Reagents for use with analyzers; Reagents for use in analysis; Reagent paper; Reactants for diagnosis; Cotton wool in the form of sticks; Cotton swabs; all of the foregoing for medical or veterinary use or purposes | ACTIVE | — |
| 042 | Analysis in the field of molecular biology; Chemical analysis services; Analytical services relating to the determination of the chemical content of liquids; Analytical services relating to the determination of the bacterial content of liquids being bacteriological analysis; Scientific analytical laboratory services; Chemical analysis; Measurement evaluation services in the field of chemical sample testing and analysis; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Bacteriological research and analysis; Biology consultancy; Technical consultancy in the field of industrial research; Consultancy in the field of scientific research; Biochemistry consultancy; Bacteriology consultancy; Consultancy relating to biotechnology; Consultancy relating to pharmaceutical research and development; Consultancy services in the field of technological development, namely, scientific consulting in the field of natural product chemical analysis for scientific research purposes; Consultancy relating to research and development in the field of therapeutics; Consultancy pertaining to pharmacology; Consultancy services relating to quality control of goods and services of others; Application system testing consultancy, namely, consultancy services for compliance with regulatory and industry standards; Advisory services relating to scientific research; Technical advisory services relating to chemical reagents; Consultancy relating to laboratory testing of psychotropic substances and natural products; Provision of information relating to technological research in the field of psychotropic substance analysis and natural product analysis; Providing information in the field of product design; Providing information about industrial analysis and research services for scientific research purposes; Providing information in the field of product development; Providing information about the results of clinical trials for pharmaceutical products; Chemical analysis, namely, assessing chemical information in relation to risks; Assessing toxicological information in relation to risks, namely, toxicology services; Pharmaceutical product evaluation; Biochemical research and analysis; Biological research and medical research; Biological research and analysis; Biological laboratory services; Biomedical research services; Biotechnological research relating to enzymatic synthesis; Biotechnological research relating to industry; Research relating to biotechnology; Soil testing services; Chemical technological research; Chemical analysis services for use in evaluation; Chemical analysis services for use in design; Chemistry consultation; Chemical research and analysis services; Chemical laboratories; Computer services for the analysis of data, namely, scientific research in the field of data interpretation of High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS) and High-Performance Liquid Chromatography coupled with nuclear magnetic resonance (HPLC-NMR) and colorimetric tests for scientific research purposes; Computer aided scientific testing, namely, testing of active compounds, natural products screening, and identification or interpretation of colorimetric tests; Computer aided industrial research services in the field of active compound and natural product analysis and development; Computer aided industrial analysis services in the field of de novo genome sequencing of fungi and bacteria; Computer aided testing services in the field of drug design and drug screening; Computer aided scientific research services; Computer aided scientific analysis services in the field of bioinformatics for natural product biosynthesis genes for scientific research purposes; Computer aided design services; Services of a chemical and biological laboratory, namely, genome sequencing of fungi and bacteria; Chemistry services, namely, scientific research in the field of multistep organic synthesis development; Scientific research laboratory services; Medical laboratory services; Medical research laboratory services; Testing of pharmaceuticals; Biotechnology testing in the nature of de novo genome sequencing; Chemical analysis services for use in the testing of material; Chemical analysis of land; Computerized food analysis services, namely, contaminant testing; Microbiological testing for scientific research purposes; Technical measuring and testing services for scientific research purposes, namely, conducting chromatography, spectroscopy, and mass spectrometry tests through the use of High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS), High-Performance Liquid Chromatography coupled with nuclear magnetic resonance (HPLC-NMR), Fourier Transform Infrared Spectroscopy, Near-Infrared Spectroscopy (FTIR/NIR), photometers, and other technical measuring and testing devices; Evaluation of chemical analyses; Behavioral analysis of chemicals; Analysis of materials, namely psychotropic substances and natural products; Product quality checking and testing services for scientific research purposes, namely, chemical compound identification and contamination analysis; Toxicity testing for research purposes; Analysis services, namely analysis of toxicity levels of drug samples and natural products samples for scientific research purposes; Environmental testing; Water analysis; Conducting of scientific studies in the field of psychoactive substances; Calibration; Development of industrial processes, namely, the cultivation and isolation of fungi and heterologous protein production for scientific research purposes; Development of new technology for others in the field of natural products production, extraction, and analysis; Development and test of chemical production methods; Development of diagnostic apparatus; Development of measuring and testing methods in the field of qualitative and quantitative drug testing; Pharmaceutical products development; Drug discovery services; Design and development of medical diagnostic apparatus; Design and development of scientific research testing and analysis methods; Design and development of diagnostic apparatus; Design and development of medical technology; Design of diagnostic apparatus and equipment, namely, laboratory or private testing instruments; Graphic design of logos for t-shirts; Product research and development; Preparation of reports in the biotechnology field for research purposes; Preparation of reports relating to scientific research; Preparation of reports relating to technical research; Surveying; Conducting environmental surveys; Providing toxicological information to others for scientific research purposes, namely, providing information on the safety, risks, and effects of chemical substances; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing scientific information, advice, and consultancy in the field of natural products development, production, and analysis; Quality control for others, namely, analysis and evaluation of product development; Research relating to molecular sciences; Technical research in the field of natural products development, production, and analysis; Research in measurement technology; Research relating to fine chemicals; Research on the subject of pharmaceuticals; Research relating to specialty chemicals; Biochemical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research and development services in the field of chemistry; Research and development services in the field of bacteriology; Research and development services in the field of antibody technology; Research and testing services in the fields of bacteriology and virology; Bacteriological research; Research and development in the field of biotechnology; Research and development in the field of diagnostic preparations; Research services in the field of natural products development, production, and analysis; Graphic design of promotional materials; Calibration services relating to electronic apparatus; Calibration services relating to analytical apparatus; Calibration of instruments; Calibration services relating to medical apparatus; Calibration services relating to computer software; Laboratory analysis in the field of chemistry; Laboratory services for analytical testing, namely, HPLC-MS, colorimetric and NMR-based natural product analysis, quantitative polymerase chain reaction (qPCR), and Next-Generation Sequencing (NGS); Research of foodstuffs; Inspection of foodstuffs; Medical research; Measurement services, namely measurement of drugs and natural compounds through qualitative and quantitative testing for scientific research purposes; Pharmaceutical research and development; Providing sample testing of drug compounds and natural products for contamination for scientific research purposes; Product development consultation; Product testing; Testing, analysis and evaluation of the services of others to determine conformity with certification standards; Quality control relating to the hygiene of foodstuffs; Quality control services in the field of drug manufacturing and natural products production; Scientific and technological services, namely, technical testing services in the field of pharmaceuticals, biotechnology, and natural products analysis; Monitoring of water quality; Environmental testing and inspection services; Laboratory testing of materials; Leasing of scientific instruments, namely, analytical testing instruments; Preparation of biological samples for research purposes; Preparation of biological samples for testing and analysis in research laboratories; Scientific services, namely, analysis of drugs and natural compounds; Advisory services relating to science; Scientific research relating to chemistry; Scientific research in the field of genetics and genetic engineering; Scientific research relating to bacteriology; Scientific research relating to biology; Scientific research in the field of pharmacy; Scientific research and development; Scientific research; Scientific laboratory services; Industrial research in the fields of biology, chemistry, genetics, genetic engineering, and pharmacy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LeadiX GmbH
- Other trademarks owned by LeadiX GmbH
- Other trademarks owned by LeadiX GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MIRACULIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 29, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 29, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 29, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 29, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 25, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 25, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 7, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 7, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 1, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 9, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 15, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 15, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 15, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 7, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 6, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 6, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 6, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 20, 2024 | ALIE | ASSIGNED TO LIE | — |
| Sep 18, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 18, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 18, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 12, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 12, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 12, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 21, 2023 | NWAP | NEW APPLICATION ENTERED | — |